Ubs Group Ag ARRIVENT BIOPHARMA INC Transaction History

Ubs Group Ag

  • $611 Billion
  • Q3 2025
Number of Shares
497,601
Previous 86,588 474.68%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
N/A
411,013 Added 474.68%
497,601 $0
Q2 2025

Aug 14, 2025
SELL
N/A
-115,597 Reduced 57.17%
86,588 $0
Q1 2025

May 13, 2025
BUY
N/A
129,492 Added 178.14%
202,185 $0
Q4 2024

Feb 14, 2025
BUY
N/A
54,057 Added 290.07%
72,693 $0
Q3 2024

Nov 14, 2024
BUY
N/A
6,651 Added 55.49%
18,636 $0
Q2 2024

Aug 13, 2024
BUY
N/A
2,090 Added 21.12%
11,985 $0
Q1 2024

May 13, 2024
BUY
N/A
9,895 New
9,895 $0
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email